|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.80 EUR | +1.20% |
|
+8.59% | -7.40% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 74.36 | +26.46% | 9 | ||||||
| 1,270.37 | +6.22% | 27 | ||||||
| 270.59 | +2.73% | 22 | ||||||
| 267.79 | +3.25% | 28 | ||||||
| 361.72 | +1.86% | 18 | ||||||
| 153.66 | -1.09% | 21 | ||||||
| 212.16 | +25.51% | 22 | ||||||
| 317.2 | -1.06% | 24 | ||||||
| 356.69 | -5.15% | 29 | ||||||
| 157.52 | +21.81% | 27 | ||||||
| 28.75 | +17.15% | 26 | ||||||
| 62.96 | +1.4% | 24 | ||||||
| 554.91 | +16.25% | 23 | ||||||
| 96.14 | +26.45% | 23 | ||||||
| 21.39 | +11.44% | 20 | ||||||
| 9,700 | +30.8% | 15 | ||||||
| 6,262.69 | +10.88% | 16 | ||||||
| 80.33 | +50.3% | 15 | ||||||
| 54.92 | +19.23% | 18 | ||||||
| Average | 1,068.64 | +13.92% | 21 | ||||||
| Weighted average by Cap. | 717.25 | +7.63% | 24 |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
